Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.24.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Nov. 30, 2024
Nov. 30, 2023
Nov. 30, 2024
Nov. 30, 2023
Operating expenses:        
General and administrative $ 2,294 $ 2,311 $ 3,898 $ 4,999
Research and development 1,409 1,079 (22,637) 2,993
Depreciation 4 8 9 18
Total operating expenses 3,707 3,398 (18,730) 8,010
Operating (loss) gain (3,707) (3,398) 18,730 (8,010)
Interest and other income (expense):        
Interest income 142   268  
Interest expense on convertible notes (1,161) (1,164) (2,326) (2,361)
Amortization of discount on convertible notes (113) (142) (238) (542)
Amortization of debt issuance costs   (3)   (369)
Issuance costs for private placement of shares and warrants through placement agent   (906)   (906)
Loss on induced conversion   (636) (1,180) (2,640)
Finance charges (9) (891) (23) (1,803)
Loss on note extinguishment   (2,406)   (4,490)
Gain on restructuring of payables 80   80  
Loss on derivatives   (17) (852) (13)
Total interest and other expenses (1,061) (6,165) (4,271) (13,124)
(Loss) gain before income taxes (4,768) (9,563) 14,459 (21,134)
Income tax benefit 0 0 0 0
Net (loss) income $ (4,768) $ (9,563) $ 14,459 $ (21,134)
(Loss) income per share:        
Basic (loss) income per share $ 0 $ (0.01) $ 0.01 $ (0.02)
Income (loss) per share, Diluted $ 0 $ (0.01) $ 0.01 $ (0.02)
Weighted average common shares used in calculation of (loss) income per share:        
Weighted average common shares outstanding, Basic 1,221,405 958,988 1,177,988 941,191
Weighted average common shares outstanding, Diluted 1,221,405 958,988 1,204,193 941,191